Drug search by name

Lenvima 4 MG Daily Dose and QT prolongation

Result of checking the interaction of drug Lenvima 4 MG Daily Dose and disease QT prolongation for safety when used together.

Check result:

Lenvima 4 MG Daily Dose <> QT prolongation

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of lenvatinib may cause QT/QTc interval prolongation. It is recommended to monitor and correct electrolyte abnormalities in all patients and to monitor electrocardiograms in patients with congenital long QT syndrome, congestive heart failure, bradyarrhythmias, or those who are taking drugs known to prolong the QT interval, including Class Ia and III antiarrhythmics. Withhold treatment with lenvatinib for the development of QTc interval prolongation greater than 500 ms. and resume treatment at a reduced dose when QTc prolongation resolves to baseline.

Lenvima 4 MG Daily Dose

Generic Name: lenvatinib

Brand Name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose

Synonyms: Lenvima

What is Lenvima 4 MG Daily Dose?